Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intrinsic blood–brain barrier dysfunction contributes to multiple sclerosis pathogenesis
Hideaki Nishihara, Sylvain Perriot, Benjamin D. Gastfriend, et al.
Brain (2022) Vol. 145, Iss. 12, pp. 4334-4348
Open Access | Times Cited: 81

Showing 1-25 of 81 citing articles:

Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience
Evridiki Asimakidou, Justin Kok Soon Tan, Jialiu Zeng, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 5, pp. 612-612
Open Access | Times Cited: 19
How does neurovascular unit dysfunction contribute to multiple sclerosis?
Jake M. Cashion, Kaylene M. Young, Brad A. Sutherland
Neurobiology of Disease (2023) Vol. 178, pp. 106028-106028
Open Access | Times Cited: 32
Blood–brain barrier dysfunction in multiple sclerosis: causes, consequences, and potential effects of therapies
Bettina Zierfuss, Catherine Larochelle, Alexandre Prat
The Lancet Neurology (2023) Vol. 23, Iss. 1, pp. 95-109
Closed Access | Times Cited: 29
Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis
Benjamin L.L. Clayton, Lilianne Barbar, Maria L. Sapar, et al.
Cell stem cell (2024) Vol. 31, Iss. 11, pp. 1701-1713.e8
Open Access | Times Cited: 9
The TIMP protein family: diverse roles in pathophysiology
Sasha Coates-Park, Joshua A. Rich, William G. Stetler‐Stevenson, et al.
AJP Cell Physiology (2024) Vol. 326, Iss. 3, pp. C917-C934
Closed Access | Times Cited: 8
Targetability of the neurovascular unit in inflammatory diseases of the central nervous system
Brandon C. Smith, Rachel A. Tinkey, Benjamin C. Shaw, et al.
Immunological Reviews (2022) Vol. 311, Iss. 1, pp. 39-49
Open Access | Times Cited: 31
The interplay between T helper cells and brain barriers in the pathogenesis of multiple sclerosis
Gabriele Angelini, Alessandro Bani, Gabriela Constantin, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 21
Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms
Karine Eid, Marte‐Helene Bjørk, Nils Erik Gilhus, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1520-1520
Open Access | Times Cited: 6
Regulatory T cell therapy for multiple sclerosis: Breaching (blood-brain) barriers
Janne Verreycken, Paulien Baeten, Bieke Broux
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 7
Open Access | Times Cited: 24
The blood-brain barrier, a key bridge to treat neurodegenerative diseases
Zhongci Hang, Liping Zhou, Cencan Xing, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102070-102070
Closed Access | Times Cited: 14
Endothelial cell‐derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis
Florian Ruiz, Benjamin Peter, Jessica Rebeaud, et al.
EMBO Reports (2023) Vol. 24, Iss. 3
Open Access | Times Cited: 13
Unraveling the Role of the Blood-Brain Barrier in the Pathophysiology of Depression: Recent Advances and Future Perspectives
Shamili Mariya Varghese, Shashikant Patel, Amritasree Nandan, et al.
Molecular Neurobiology (2024) Vol. 61, Iss. 12, pp. 10398-10447
Closed Access | Times Cited: 5
Precise Modulation of Pericyte Dysfunction by a Multifunctional Nanoprodrug to Ameliorate Alzheimer’s Disease
Peng Yang, Yixian Li, Kang Qian, et al.
ACS Nano (2024) Vol. 18, Iss. 22, pp. 14348-14366
Closed Access | Times Cited: 5
Multiple sclerosis and infection: history, EBV, and the search for mechanism
Elliott D. SoRelle, Micah A. Luftig
Microbiology and Molecular Biology Reviews (2025)
Closed Access
Ginsenoside Rb1 alleviates blood-brain barrier damage and demyelination in experimental autoimmune encephalomyelitis mice by regulating JNK/ ERK/NF-κB signaling pathway
Yingying Song, Xiaojuan Zhang, Xinyan Han, et al.
Journal of Ethnopharmacology (2025), pp. 119448-119448
Closed Access
Oligodendrocyte Precursor Cell-Specific HMGB1 Knockout Reduces Immune Cell Infiltration and Demyelination in Experimental Autoimmune Encephalomyelitis Models
Gil‐Ran Kim, Jihye Seo, Bokyung Kim, et al.
Neuroscience Bulletin (2025)
Closed Access
In Vitro Models of the Blood–Brain Barrier to Study Multiple Sclerosis Pathogenesis
Miwako Fujisawa, Hideaki Nishihara, Britta Engelhardt
Current human cell research and applications (2025), pp. 209-231
Closed Access
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
Pauline van Schaik, Inge S. Zuhorn, Wia Baron
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8418-8418
Open Access | Times Cited: 19
Immunomodulatory and Anti-inflammatory effect of Neural Stem/Progenitor Cells in the Central Nervous System
Wei Ni, Murugan Ramalingam, Yumeng Li, et al.
Stem Cell Reviews and Reports (2023) Vol. 19, Iss. 4, pp. 866-885
Closed Access | Times Cited: 11
Transcobalamin receptor antibodies in autoimmune vitamin B12 central deficiency
John V. Pluvinage, Thomas Ngo, Camille Fouassier, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 753
Open Access | Times Cited: 4
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access
The Rise of Pluripotent Stem Cell-Derived Glia Models of Neuroinflammation
Srishti Kala, Andrew G. Strutz, Moriah E. Katt
Neurology International (2025) Vol. 17, Iss. 1, pp. 6-6
Open Access
Recent advances, strategies, and future perspectives of peptide-based drugs in clinical applications
Qimeng Yang, Zhipeng Hu, Hongyu Jiang, et al.
Chinese Journal of Natural Medicines (2025) Vol. 23, Iss. 1, pp. 31-42
Closed Access
An anti-CD19-exosome delivery system navigates the blood–brain barrier for targeting of central nervous system lymphoma
Meifang Zhao, Qi Li, Yali Chai, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Impact of Peripheral Inflammation on Blood–Brain Barrier Dysfunction and Its Role in Neurodegenerative Diseases
Ana Isabel Beltrán-Velasco, Vicente Javier Clemente‐Suárez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2440-2440
Open Access
Page 1 - Next Page

Scroll to top